i & o med limited

i & o med limited Company Information

Share I & O MED LIMITED
Live 
EstablishedSmallHealthy

Company Number

07963347

Industry

General medical practice activities

 

Shareholders

ibtihal al-jbouri

omar aldabbagh

Group Structure

View All

Contact

Registered Address

floor 2 9 portland street, manchester, M1 3BE

i & o med limited Estimated Valuation

£1.2m

Pomanda estimates the enterprise value of I & O MED LIMITED at £1.2m based on a Turnover of £3m and 0.41x industry multiple (adjusted for size and gross margin).

i & o med limited Estimated Valuation

£758.7k

Pomanda estimates the enterprise value of I & O MED LIMITED at £758.7k based on an EBITDA of £230.4k and a 3.29x industry multiple (adjusted for size and gross margin).

i & o med limited Estimated Valuation

£2.8m

Pomanda estimates the enterprise value of I & O MED LIMITED at £2.8m based on Net Assets of £1m and 2.73x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

I & O Med Limited Overview

I & O Med Limited is a live company located in manchester, M1 3BE with a Companies House number of 07963347. It operates in the general medical practice activities sector, SIC Code 86210. Founded in February 2012, it's largest shareholder is ibtihal al-jbouri with a 50% stake. I & O Med Limited is a established, small sized company, Pomanda has estimated its turnover at £3m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

I & O Med Limited Health Check

Pomanda's financial health check has awarded I & O Med Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

6 Strong

positive_score

1 Regular

positive_score

3 Weak

size

Size

annual sales of £3m, make it larger than the average company (£1.2m)

£3m - I & O Med Limited

£1.2m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (10.6%)

13% - I & O Med Limited

10.6% - Industry AVG

production

Production

with a gross margin of 23.4%, this company has a higher cost of product (45.2%)

23.4% - I & O Med Limited

45.2% - Industry AVG

profitability

Profitability

an operating margin of 7.8% make it more profitable than the average company (5.2%)

7.8% - I & O Med Limited

5.2% - Industry AVG

employees

Employees

with 2 employees, this is below the industry average (16)

2 - I & O Med Limited

16 - Industry AVG

paystructure

Pay Structure

on an average salary of £36.1k, the company has an equivalent pay structure (£36.1k)

£36.1k - I & O Med Limited

£36.1k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £1.5m, this is more efficient (£90.4k)

£1.5m - I & O Med Limited

£90.4k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 156 days, this is later than average (36 days)

156 days - I & O Med Limited

36 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 37 days, this is slower than average (26 days)

37 days - I & O Med Limited

26 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - I & O Med Limited

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - I & O Med Limited

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 19.7%, this is a lower level of debt than the average (53.7%)

19.7% - I & O Med Limited

53.7% - Industry AVG

I & O MED LIMITED financials

EXPORTms excel logo

I & O Med Limited's latest turnover from February 2024 is estimated at £3 million and the company has net assets of £1 million. According to their latest financial statements, I & O Med Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Feb 2024Feb 2023Feb 2022Feb 2021Feb 2020Feb 2019Feb 2018Feb 2017Feb 2016Feb 2015Feb 2014Feb 2013
Turnover2,950,7372,261,4802,243,2432,048,2661,146,7431,449,668969,82973,560107,324187,190265,79337,112
Other Income Or Grants000000000000
Cost Of Sales2,261,7401,758,5001,715,4901,545,044850,9041,094,068674,13647,80976,783134,394177,50125,344
Gross Profit688,997502,980527,753503,222295,839355,600295,69225,75230,54152,79688,29211,768
Admin Expenses458,620289,211362,452363,673211,098264,185200,839-32,168-44,2282,89295,393-72,701
Operating Profit230,377213,769165,301139,54984,74191,41594,85357,92074,76949,904-7,10184,469
Interest Payable000000000000
Interest Receivable0000006065146652786530
Pre-Tax Profit230,377213,769165,301139,54984,74191,41595,45958,43475,43450,182-7,03684,499
Tax-57,594-40,616-31,407-26,514-16,101-17,369-18,137-11,687-15,087-10,5380-20,280
Profit After Tax172,783173,153133,894113,03568,64074,04677,32246,74760,34739,644-7,03664,219
Dividends Paid000000000000
Retained Profit172,783173,153133,894113,03568,64074,04677,32246,74760,34739,644-7,03664,219
Employee Costs72,13667,01863,70261,97366,048326,889239,74934,41228,94854,06450,92627,254
Number Of Employees222229711221
EBITDA*230,377213,769165,301139,54984,74191,41594,85359,34975,99350,593-6,88184,469

* Earnings Before Interest, Tax, Depreciation and Amortisation

Feb 2024Feb 2023Feb 2022Feb 2021Feb 2020Feb 2019Feb 2018Feb 2017Feb 2016Feb 2015Feb 2014Feb 2013
Tangible Assets2229395270941251,0641,7831,3461,2460
Intangible Assets000000000000
Investments & Other000000000000
Debtors (Due After 1 year)000000000000
Total Fixed Assets2229395270941251,0641,7831,3461,2460
Stock & work in progress000000000000
Trade Debtors1,266,2501,102,7051,011,108904,150494,611464,130323,713019,46631,49056,4944,439
Group Debtors000000000000
Misc Debtors0000000000075,000
Cash0000000242,355168,92297,01014,17011,818
misc current assets000000000000
total current assets1,266,2501,102,7051,011,108904,150494,611464,130323,713242,355188,388128,50070,66491,257
total assets1,266,2721,102,7341,011,147904,202494,681464,224323,838243,419190,171129,84671,91091,257
Bank overdraft000000000000
Bank loan000000000000
Trade Creditors 234,411234,255306,421317,23870,752108,93542,59539,39832,54032,65014,62726,938
Group/Directors Accounts000000000000
other short term finances000000000000
hp & lease commitments000000000000
other current liabilities000000000000
total current liabilities234,411234,255306,421317,23870,752108,93542,59539,39832,54032,65014,62726,938
loans000000000000
hp & lease commitments000000000000
Accruals and Deferred Income000000000000
other liabilities15,06724,46833,86850,00000000000
provisions0000000035726900
total long term liabilities15,06724,46833,86850,000000035726900
total liabilities249,478258,723340,289367,23870,752108,93542,59539,39832,89732,91914,62726,938
net assets1,016,794844,011670,858536,964423,929355,289281,243204,021157,27496,92757,28364,319
total shareholders funds1,016,794844,011670,858536,964423,929355,289281,243204,021157,27496,92757,28364,319
Feb 2024Feb 2023Feb 2022Feb 2021Feb 2020Feb 2019Feb 2018Feb 2017Feb 2016Feb 2015Feb 2014Feb 2013
Operating Activities
Operating Profit230,377213,769165,301139,54984,74191,41594,85357,92074,76949,904-7,10184,469
Depreciation00000001,4291,2246892200
Amortisation000000000000
Tax-57,594-40,616-31,407-26,514-16,101-17,369-18,137-11,687-15,087-10,5380-20,280
Stock000000000000
Debtors163,54591,597106,958409,53930,481140,417323,713-19,466-12,024-25,004-22,94579,439
Creditors156-72,166-10,817246,486-38,18366,3403,1976,858-11018,023-12,31126,938
Accruals and Deferred Income000000000000
Deferred Taxes & Provisions0000000-3578826900
Cash flow from operations9,3949,39016,119-50,018-24-31-243,80073,62972,90883,3513,75311,688
Investing Activities
capital expenditure71013182431939-710-1,661-789-1,4660
Change in Investments000000000000
cash flow from investments71013182431939-710-1,661-789-1,4660
Financing Activities
Bank loans000000000000
Group/Directors Accounts000000000000
Other Short Term Loans 000000000000
Long term loans000000000000
Hire Purchase and Lease Commitments000000000000
other long term liabilities-9,401-9,400-16,13250,00000000000
share issue000000-1000000100
interest0000006065146652786530
cash flow from financing-9,401-9,400-16,13250,0000050651466527865130
cash and cash equivalents
cash000000-242,35573,43371,91282,8402,35211,818
overdraft000000000000
change in cash000000-242,35573,43371,91282,8402,35211,818

i & o med limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for i & o med limited. Get real-time insights into i & o med limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

I & O Med Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for i & o med limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in M 1 area or any other competitors across 12 key performance metrics.

i & o med limited Ownership

I & O MED LIMITED group structure

I & O Med Limited has no subsidiary companies.

Ultimate parent company

I & O MED LIMITED

07963347

I & O MED LIMITED Shareholders

ibtihal al-jbouri 50%
omar aldabbagh 50%

i & o med limited directors

I & O Med Limited currently has 2 directors. The longest serving directors include Dr Omar Aldabbagh (Feb 2012) and Mrs Ibtihal Aljbouri (Sep 2012).

officercountryagestartendrole
Dr Omar AldabbaghUnited Kingdom57 years Feb 2012- Director
Mrs Ibtihal AljbouriUnited Kingdom41 years Sep 2012- Director

P&L

February 2024

turnover

3m

+30%

operating profit

230.4k

0%

gross margin

23.4%

+4.99%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

February 2024

net assets

1m

+0.2%

total assets

1.3m

+0.15%

cash

0

0%

net assets

Total assets minus all liabilities

i & o med limited company details

company number

07963347

Type

Private limited with Share Capital

industry

86210 - General medical practice activities

incorporation date

February 2012

age

13

incorporated

UK

ultimate parent company

None

accounts

Micro-Entity Accounts

last accounts submitted

February 2024

previous names

N/A

accountant

-

auditor

-

address

floor 2 9 portland street, manchester, M1 3BE

Bank

-

Legal Advisor

-

i & o med limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to i & o med limited.

i & o med limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for I & O MED LIMITED. This can take several minutes, an email will notify you when this has completed.

i & o med limited Companies House Filings - See Documents

datedescriptionview/download